Nanobiotix SA

3.3560

24-January-25 11:13:04

15 minutes delayed

Stocks

+0.1940

+6.14%

Today's range

3.2000 - 3.3900

ISIN

FR0011341205

Source

Cboe

NANOBIOTIX Entering Final Contract Negotiations Following Agreement to Non-Binding Term Sheet for Development and Commercialization of NBTXR3 With a Major Global Pharmaceutical Company

05 May 2023 01:30:00 By Nasdaq GlobeNewswire
NANOBIOTIX Provides Business Update and Reports Full Year 2022 Financial Results

24 Apr 2023 19:33:54 By Nasdaq GlobeNewswire
NANOBIOTIX to Provide Operational Update and Report Full Year 2022 Financial Results on April 24, 2023

17 Apr 2023 16:15:00 By Nasdaq GlobeNewswire
Voting Rights and Shares Capital of the Company

11 Apr 2023 16:15:00 By Nasdaq GlobeNewswire
Nanobiotix to Postpone Full Year 2022 Financial Results and Conference Call

27 Mar 2023 16:15:00 By Nasdaq GlobeNewswire
Nanobiotix to Provide Operational Update and Report Full Year 2022 Financial Results on March 28, 2023

14 Mar 2023 16:15:00 By Nasdaq GlobeNewswire
Voting Rights and Shares Capital of the Company

14 Feb 2023 16:15:00 By Nasdaq GlobeNewswire
Voting Rights and Shares Capital of the Company

11 Jan 2023 16:15:00 By Nasdaq GlobeNewswire
NANOBIOTIX Announces First Patient Randomized in the United States in Global Phase 3 Pivotal Trial Evaluating Radioenhancer NBTXR3 in Head and Neck Cancer

27 Dec 2022 01:45:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.